CHRISTOPHER FOSTER: Open Payments
NPI 1295081123 · WAXHAW, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 24 payments from 9 companies in 2025. Trend: 2023 $33 · 2024 $159 · 2025 $583
Food & beverage: $583
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $187 |
| Novo Nordisk Inc | 10 | $155 |
| GENZYME CORPORATION | 1 | $84 |
| ABBVIE INC. | 2 | $39 |
| SHIELD THERAPEUTICS INC | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Amgen Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Lilly USA, LLC | 1 | $14 |
Products named: AIRSUPRA, FABRAZYME, Wegovy, VRAYLAR, Ozempic, ACCRUFER, LEQVIO, EVENITY.
Industry payments across NC — which companies pay providers there.
